Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Gains from Investment Securities (2016 - 2026)

Phibro Animal Health has reported Gains from Investment Securities over the past 13 years, most recently at -$2.9 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 285.98% year-over-year to -$2.9 million; the TTM value through Dec 2025 reached -$1.2 million, down 139.07%, while the annual FY2025 figure was $4.5 million, 646.94% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$2.9 million at Phibro Animal Health, down from $3.7 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $3.7 million in Q3 2025 and troughed at -$2.9 million in Q4 2025.
  • A 5-year average of $91400.0 and a median of $275000.0 in 2022 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 600.0% in 2021 and later surged 667.23% in 2025.
  • Year by year, Gains from Investment Securities stood at -$1.0 million in 2021, then crashed by 34.4% to -$1.3 million in 2022, then crashed by 77.75% to -$2.4 million in 2023, then soared by 164.8% to $1.5 million in 2024, then tumbled by 285.98% to -$2.9 million in 2025.
  • Business Quant data shows Gains from Investment Securities for PAHC at -$2.9 million in Q4 2025, $3.7 million in Q3 2025, and $241000.0 in Q2 2025.